Počet záznamov: 1
granulomatóza s polyangiitídou
SYS d014890 LBL 00000cz--a2200000n--4500 005 20250606213236.4 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a C08.381.483.950 065 $a C14.907.940.897.249.750 065 $a C17.800.862.105.875 065 $a C20.111.193.875 066 $a 01 $c 03 150 $a granulomatóza s polyangiitídou $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a Granulomatosis, Wegener's $2 eng 450 $w v $a Wegener Granulomatosis $2 eng 450 $w v $a Wegenerova granulomatóza $2 slo 550 $7 sllk_us_auth*d020293 $Y Vasculitis, Central Nervous System $w p $a vaskulitída centrálneho nervového systému 550 $7 sllk_us_auth*d053146 $Y Myeloblastin $w p $a myeloblastín 550 $7 sllk_us_auth*d053146 $Y Myeloblastin $w b $a myeloblastín 665 $a 2015(1963) $2 eng 680 9-
$i A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN. $2 eng 750 -2
$a Granulomatosis with Polyangiitis $2 eng 980 $x M
Počet záznamov: 1